Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patien

RELIEF THERAPEUTICS Holding AG / Key word(s): Research Update27-Jan-2022 / 07:15 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient...

Related Keywords

Geneva ,Genè ,Switzerland ,Swiss ,Michael Miller ,Jack Weinstein ,Jonathan Javitt ,Advita Lifescience Gmb ,Linkedin ,Pharma Research ,Swiss Exchange ,Nrx Pharmaceuticals Inc ,Rx Communications Group ,Nasdaq ,Holding Ag Key ,Neurorx Inc ,Announced Receipt ,Initial Report ,Patient Safety ,Try Use ,Aviptadil During Omicron ,Federal Right ,Try Law ,Vasoactive Intestinal Peptide ,License Agreement ,Acer Therapeutics ,Urea Cycle Disorders ,Maple Syrup Urine ,Advita Lifescience Gmbh ,Financial Officer ,